|Bid||0.00 x 1100|
|Ask||20.85 x 1000|
|Day's Range||18.05 - 21.09|
|52 Week Range||15.01 - 82.81|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Canopy Growth's new CEO David Klein delivered first quarter results that topped expectations across the board as shares popped 15%.
Canada's market today mirrors the patchwork of U.S. states where the drug is legal in the worst possible ways, according to one analyst.
Investors are bracing for more job cuts and writedowns at Canadian cannabis producers before the industry stabilizes and becomes profitable, after two of the biggest weed companies, Aurora Cannabis and Tilray announced cost reductions this week. Canada legalized recreational cannabis in October 2018 but profits have proven elusive for most marijuana companies as fewer-than-expected retail stores, higher prices than on the black market and slow overseas growth resulted in oversupply. "The Aurora story will be much more common in 2020," said Hap Sneddon, founder and chief portfolio manager at Castlemoore.
A Canadian exchange traded fund provider is winding down its cannabis offering as shares of publicly traded pot companies continue to slump.
Shares of Canadian pot producer Aprhia climbed nearly 10 per cent on Wednesday after the company announced a significant step towards improving sales in Europe’s largest cannabis market.
Despite waning investor optimism in the cannabis space, AdvisorShares CEO Noah Hamman says 2020 could be a big year for the sector.
Israel's InterCure Ltd said on Thursday its subsidiary Canndoc has signed a strategic cooperation agreement with Tilray Inc for the import and export of medical cannabis. Canndoc has an option to import 2.5 tonnes of high quality cannabis from Tilray's facilities in Portugal, with a first shipment of 250 kilograms already on its way to Israel. Canndoc said to its knowledge this is the first medical marijuana imported commercially to Israel.
Following the final release of Opportunity Zone regulations on December 19, investors in cannabis dispensaries stand to benefit, some say.
Let's dive into five strong stocks currently trading for under $20 per share we found with our Zacks Stock Screener that investors might want to buy for 2020...